Nuwellis Inc Revenue Growth Rates (NUWE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Nuwellis Inc   (NASDAQ: NUWE)
 

NUWE's Revenue Growth by Quarter and Year

Nuwellis Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUWE Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.97
1st Quarter March 2.40
FY 4.37

NUWEs Annual Revenue
Nuwellis Inc 's Revenue in the fiscal year 2025 $ 8.27 millions
Nuwellis Inc 's Revenue in the fiscal year 2024 $ 8.68 millions
Nuwellis Inc 's Revenue in the fiscal year 2023 $ 7.98 millions
Nuwellis Inc 's Revenue in the fiscal year 2022 $ 8.54 millions
Nuwellis Inc 's Revenue in the fiscal year 2021 $ 7.92 millions




NUWE Revenue second quarter 2026 Y/Y Growth Comment
Nuwellis Inc achieved in the second quarter 2026, above Company average Revenue increase of 13.82% year on year, to $ 1.97 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 77 other companies have achieved higher Revenue growth. While Nuwellis Inc ' s Revenue growth of 13.82% ranks overall at the positon no. 1377 in the second quarter 2026.


NUWE Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 8.04 % 31.76 % -27.35 %
3rd Quarter September - -6.33 % -0.42 % 14.98 %
2nd Quarter June 13.82 % -21 % 5.29 % -5.88 %
1st Quarter March 26.32 % 2.15 % 1.64 % -5.18 %
FY   - -4.5 % 8.39 % -

Financial Statements
Nuwellis Inc 's second quarter 2026 Revenue $ 1.97 millions NUWE's Income Statement
Nuwellis Inc 's second quarter 2025 Revenue $ 1.73 millions Quarterly NUWE's Income Statement


NUWE Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 9.01 % -5.49 % -28.57 %
3rd Quarter September - 28.32 % 8.22 % 14.42 %
2nd Quarter June -17.96 % -8.95 % 17.74 % 13.66 %
1st Quarter March -0.83 % -15.18 % 9.41 % -21.79 %
FY (Year on Year)   - -4.5 % 8.39 % -


Back to NUWE Growth rate Comparisons >> Back to NUWE Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #78
Healthcare Sector #242
Overall #1377

Revenue Y/Y Growth Statistics
High Average Low
80.39 % 6.43 % -100 %
(Jun 30 2019)   (Jun 30 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #78
Healthcare Sector #242
Overall #1377
Revenue Y/Y Growth Statistics
High Average Low
80.39 % 6.43 % -100 %
(Jun 30 2019)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Nuwellis Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
200 % 0.54 % -100 %
(Dec 31 2014)  


NUWE's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Nuwellis Inc disclosed fall in Revenue from the first quarter by -17.96% to $ 1.97 millions, from $ 2.40 millions achived in the previous reporting period.

But that's not important problem, as Nuwellis Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 142 other companies have achieved higher Revenue quarter on quarter growth. While Nuwellis Inc 's Revenue growth quarter on quarter, overall rank is 3174.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #143
Healthcare Sector #429
Overall #3174
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #143
Healthcare Sector #429
Overall #3174
Revenue Q/Q Growth Statistics
High Average Low
200 % 0.54 % -100 %
(Dec 31 2014)  


NUWE's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Nuwellis Inc disclosed fall in Revenue from the first quarter by -17.96% to $ 1.97 millions, from $ 2.40 millions achived in the previous reporting period.

But that's not important problem, as Nuwellis Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 142 other companies have achieved higher Revenue quarter on quarter growth. While Nuwellis Inc 's Revenue growth quarter on quarter, overall rank is 3174.


Nuwellis Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 9.01 $ 8.77 $ 8.27 $ 8.09 $ 8.24
Y / Y Revenue Growth (TTM) 9.38 % 0.69 % -4.53 % -0.36 % 1.32 %
Year on Year Revenue Growth Overall Ranking # 2469 # 1459 # 2038 # 2198 # 2426
Seqeuential Revenue Change (TTM) 2.78 % 6.03 % 2.22 % -1.82 % -5.39 %
Seq. Revenue Growth (TTM) Overall Ranking # 2971 # 1664 # 2248 # 1894 # 1976


Cumulative Revenue growth Comment
Although Nuwellis Inc 's Annual Revenue growth year on year were below company's average 12.7% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 9.38% year on year, from 0.69% in Mar 31 2026.

In the Healthcare sector 358 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1459 to 2469.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 359
Overall # 2469

Revenue TTM Y/Y Growth Statistics
High Average Low
46.64 %
 12.7 %
-8.84 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 148
Sector # 413
S&P 500 # 2971
Cumulative Revenue growth Comment
Although Nuwellis Inc 's Annual Revenue growth year on year were below company's average 12.7% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 9.38% year on year, from 0.69% in Mar 31 2026.

In the Healthcare sector 358 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1459 to 2469.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 359
Overall # 2469

Revenue TTM Y/Y Growth Statistics
High Average Low
46.64 %
12.7 %
-8.84 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 148
Sector # 413
S&P 500 # 2971




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NUWE's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions
Axogen inc 23.06%$ 23.065 millions
Vericel Corporation22.48%$ 22.481 millions
Milestone Scientific Inc 22.28%$ 22.276 millions
Alpha Teknova Inc 22.05%$ 22.045 millions
X4 Pharmaceuticals Inc21.64%$ 21.642 millions
Exagen Inc 21.63%$ 21.629 millions
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions
Anika Therapeutics Inc 19.18%$ 19.176 millions
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions
Camp4 Therapeutics Corporation18.84%$ 18.838 millions
Lensar Inc 18.37%$ 18.371 millions


About Nuwellis Inc Revenue Growth Rates (NUWE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Nuwellis Inc (CIK 1506492).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001140361-26-032810
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Nuwellis Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.